![Carina Namih](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carina Namih
Fondateur chez Helix Nanotechnologies, Inc.
Profil
Carina Namih is the founder of Helix Nanotechnologies, Inc. She is currently a General Partner at Plural UK Management Ltd.
She was formerly a General Partner at Episode 1 Ventures LLP.
She received an undergraduate degree from the University of Oxford.
Postes actifs de Carina Namih
Sociétés | Poste | Début |
---|---|---|
Helix Nanotechnologies, Inc.
![]() Helix Nanotechnologies, Inc. Packaged SoftwareTechnology Services Helix Nanotechnologies, Inc. provides software and biomedicine services. Its technology is programmable deoxyribonucleic acid which is use for early applications, including gene assembly and editing synthetic biology. The company was founded in 2013 and is headquartered in San Francisco, California. | Fondateur | - |
Plural Uk Management Ltd. | Private Equity Investor | 24/03/2023 |
Anciens postes connus de Carina Namih
Sociétés | Poste | Fin |
---|---|---|
Episode 1 Ventures LLP
![]() Episode 1 Ventures LLP Investment ManagersFinance Episode 1 Ventures LLP (Episode 1 Ventures) is an independent venture capital firm founded by Simon Murdoch and Richard Tahta in 1999. The firm is headquartered in London. | Private Equity Investor | - |
Formation de Carina Namih
University of Oxford | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Episode 1 Ventures LLP
![]() Episode 1 Ventures LLP Investment ManagersFinance Episode 1 Ventures LLP (Episode 1 Ventures) is an independent venture capital firm founded by Simon Murdoch and Richard Tahta in 1999. The firm is headquartered in London. | Finance |
Helix Nanotechnologies, Inc.
![]() Helix Nanotechnologies, Inc. Packaged SoftwareTechnology Services Helix Nanotechnologies, Inc. provides software and biomedicine services. Its technology is programmable deoxyribonucleic acid which is use for early applications, including gene assembly and editing synthetic biology. The company was founded in 2013 and is headquartered in San Francisco, California. | Technology Services |
Plural Uk Management Ltd. | Finance |